Hematologia.La Sangre Y Sus Enfermedades

Total Page:16

File Type:pdf, Size:1020Kb

Hematologia.La Sangre Y Sus Enfermedades Hematología La sangre y sus enfermedades Hematología La sangre y sus enfermedades Segunda edición José Carlos Jaime Pérez Subdirector de Estudios de Posgrado de la Facultad de Medicina y del Hospital Universitario “Dr. José E. González” Universidad Autónoma de Nuevo León Jefe de Enseñanza e Investigación del Servicio de Hematología Universidad Autónoma de Nuevo León Doctor en Medicina Inmunohematólogo Dr. David Gómez Almaguer Hematólogo, Profesor de Hematología y Medicina Interna, Jefe del Servicio de Hematología del Centro Universitario Contra el Cáncer, Facultad de Medicina y Hospital Universitario “Dr. José E. González” de la Universidad Autónoma de Nuevo León, Monterrey, México Investigador Nacional, Sistema Nacional de Investigadores, Miembro de la Academia Nacional de Medicina y de la Academia Mexicana de Ciencias MÉXICO • BOGOTÁ • BUENOS AIRES • CARACAS • GUATEMALA • LISBOA MADRID • NUEVA YORK • SAN JUAN • SANTIAGO • SAO PAULO AUCKLAND • LONDRES • MILÁN • MONTREAL • NUEVA DELHI SAN FRANCISCO • SIDNEY • SINGAPUR • ST. LOUIS • TORONTO Director editorial: Javier de León Fraga Editor sponsor: Gabriel Romero Hernández Supervisor de edición: Norma Leticia García Carbajal Supervisor de producción: José Luis González Huerta Corrección de estilo: Eduardo Grijalva Gómez NOTA La medicina es una ciencia en constante desarrollo. Conforme surjan nuevos conocimientos, se requerirán cambios de la terapéutica. El (los) autor(es) y los editores se han esforzado para que los cuadros de dosificación medicamentosa sean precisos y acordes con lo establecido en la fecha de publicación. Sin embargo, ante los posibles errores humanos y cambios en la medicina, ni los editores ni cualquier otra persona que haya participado en la preparación de la obra garantizan que la información contenida en ella sea precisa o completa, tampoco son responsables de errores u omisiones, ni de los resultados que con dicha información se obtengan. Convendría recurrir a otras fuentes de datos, por ejemplo, y de manera particular, habrá que consultar la hoja informativa que se adjunta con cada medicamento, para tener certeza de que la información de esta obra es precisa y no se han introducido cambios en la dosis recomendada o en las contraindicaciones para su administración. Esto es de particular importancia con respecto a fármacos nuevos o de uso no frecuente. También deberá consultarse a los laboratorios para recabar información sobre los valores normales. HEMATOLOGÍA. LA SANGRE Y SUS ENFERMEDADES Prohibida la reproducción total o parcial de esta obra, por cualquier medio, sin la autorización escrita del editor. DERECHOS RESERVADOS © 2009, 2005 respecto a la segunda edición en español por, McGRAW-HILL INTERAMERICANA EDITORES, S.A. DE C.V. A Subsidiary of Th e McGraw-Hill Companies, Inc. Prolongación Paseo de la Reforma 1015, Torre A, Piso 17, Col. Desarrollo Santa Fe, Delegación Álvaro Obregón, C.P. 01376, México, D.F. Miembro de la Cámara Nacional de la Industria Editorial Mexicana, Reg. Núm. 736 ISBN-13: 978-970-10-6920-2 1234567890 08765432109 Impreso en México Printed in Mexico Contenido Capítulo 1 Capítulo 8 Célula madre hematopoyética Esferocitosis hereditaria 35 y hematopoyesis 1 Dr. José Carlos Jaime Pérez Dr. José Carlos Jaime Pérez Dr. David Gómez Almaguer Capítulo 9 Defi ciencia de la deshidrogenasa Capítulo 2 de glucosa-6-fosfato (G6PD) 39 Breve historia de la hematología I: Dr. José Carlos Jaime Pérez las anemias 5 Capítulo 10 Dr. José Carlos Jaime Pérez Drepanocitosis 43 Dr. José Carlos Jaime Pérez Capítulo 3 Anemia: consideraciones generales Capítulo 11 y clasifi cación 13 Talasemias 47 Dr. David Gómez Almaguer Dr. Guillermo Ruiz Reyes Capítulo 4 Capítulo 12 Interpretación de la biometría hemática 17 Anemia hemolítica autoinmune 51 Dr. José Carlos Jaime Pérez Dr. Carlos Almaguer Gaona Capítulo 13 Capítulo 5 Enfermedad hemolítica del recién nacido 57 Anemia ferropénica 23 Dr. Óscar González Llano Dr. Óscar González Llano Capítulo 14 Capítulo 6 Hemoglobinuria paroxística nocturna 61 Anemia megaloblástica 27 Dr. Carlos Almaguer Gaona Dr. David Gómez Almaguer Capítulo 15 Capítulo 7 Hemocromatosis 67 Dr. Guillermo J. Ruiz Delgado Anemia aplásica 31 Dr. Guillermo J. Ruiz Argüelles Dra. Olga Graciela Cantú Rodríguez Dr. Miguel A. Gómez Guijosa vi Contenido Capítulo 16 Capítulo 26 Breve historia de la hematología II. Mieloma múltiple 123 Las leucemias 71 Dr. Jorge Vela Ojeda Dr. José Carlos Jaime Pérez Dra. Miriam A. García Ruiz Esparza Capítulo 17 Capítulo 27 Leucemia linfoblástica aguda 77 Macroglobulinemia de Waldenström 129 Dr. David Gómez Almaguer Dr. José Carlos Jaime Pérez Dr. José Carlos Jaime Pérez Capítulo 28 Capítulo 18 Breve historia de la hematología IV: Leucemia mieloblástica aguda 83 Dr. David Gómez Almaguer la coagulación sanguínea 133 Dr. José Carlos Jaime Pérez Capítulo 19 Capítulo 29 Leucemia linfocítica crónica y leucemia de células pilosas 87 Fisiología de la coagulación I. Dra. Olga Graciela Cantú Rodríguez Función plaquetaria 137 Dr. José Carlos Jaime Pérez Dr. Luis Javier Marfi l Rivera Capítulo 20 Capítulo 30 Leucemia granulocítica crónica 93 Fisiología de la coagulación II. Dr. José Luis Herrera Garza Dra. Olga Graciela Cantú Rodríguez Fases plasmática y fi brinolítica 145 Dr. Luis Javier Marfi l Rivera Capítulo 21 Síndromes mieloproliferativos crónicos: Capítulo 31 policitemia vera, trombocitosis esencial Evaluacion del paciente y mielofi brosis 97 con hemorragia anormal 155 Dra. Olga Graciela Cantú Rodríguez Dr. Luis Javier Marfi l Rivera Capítulo 22 Capítulo 32 Síndromes mielodisplásicos 103 Enfermedades hemorrágicas por defectos Dr. David Gómez Almaguer vasculares y plaquetarios 161 Capítulo 23 Dr. Luis Javier Marfi l Rivera Breve historia de la hematología III. Capítulo 33 Los linfomas y el mieloma múltiple 107 Dr. José Carlos Jaime Pérez Enfermedades hemorrágicas por defectos de la fase plasmática y de la fi brinólisis 169 Capítulo 24 Dr. Luis Javier Marfi l Rivera Linfoma de Hodgkin 113 Dr. David Gómez Almaguer Capítulo 34 Dr. Homero Gutiérrez Aguirre Estado hipercoagulable. Trombofi lia 179 Capítulo 25 Dr. Luis Javier Marfi l Rivera. Linfomas no Hodgkin 117 Capítulo 35 Dr. David Gómez Almaguer Dr. Homero Gutiérrez Aguirre Púrpura trombocitopénica inmunológica 185 Dr. José Carlos Jaime Pérez Dr. José Carlos Jaime Pérez Contenido vii Capítulo 36 Capítulo 45 Púrpura trombocitopénica trombótica Banco de sangre de cordón umbilical 235 y síndrome urémico hemolítico 191 Dra. Consuelo Mancías Guerra Dr. David Gómez Almaguer Dra. Luz del Carmen Tarín Arzaga Capítulo 46 Dr. José Carlos Jaime Pérez Sistema HLA y su importancia en hematología 241 Capítulo 37 Dr. José Carlos Jaime Pérez Breve historia de la hematología V. Capítulo 47 La transfusión sanguínea y el trasplante de células hematopoyéticas 195 Trasplante de células progenitoras Dr. José Carlos Jaime Pérez hematopoyéticas 245 Dr. David Gómez Almaguer Capítulo 38 Dr. José Carlos Jaime Pérez Introducción a la medicina de transfusión 201 Capítulo 48 Dr. José Carlos Jaime Pérez Principios de inmunología aplicados Dr. Mario César Salinas Carmona a la hematología 251 Dr. Mario César Salinas Carmona Capítulo 39 Pruebas de compatibilidad previas Capítulo 49 a la transfusión y la prueba de la Fundamentos de biología antiglobulina humana o de Coombs 205 molecular en hematología 259 Dr. Carlos Almaguer Gaona Dr. Javier Garcés Eisele Dra. Virginia Reyes Núñez Capítulo 40 Dr. Alejandro Ruiz Argüelles Terapia con componentes sanguíneos 211 Capítulo 50 Dr. José Carlos Jaime Pérez Biología molecular en las enfermedades Capítulo 41 hematológicas 263 Dr. Javier Garcés Eisele Guías para la transfusión sanguínea 219 Dra. Virginia Reyes Núñez Dr. José Carlos Jaime Pérez Dr. Alejandro Ruiz Argüelles Dr. Eduardo Vázquez Garza Capítulo 51 Capítulo 42 Valores normales y pruebas especiales Aspectos prácticos de la transfusión en el laboratorio de hematología 271 de la sangre y sus fracciones 223 Dr. Carlos Almaguer Gaona Dr. José Carlos Jaime Pérez Capítulo 52 Capítulo 43 El frotis de la sangre periférica Transfusión masiva 227 en las enfermedades hematológicas Dr. Luis Javier Marfi l Rivera más frecuentes 279 Dra. Luz del Carmen Tarín Arzaga Capítulo 44 Glosario 285 Hemoféresis 231 Dr. José Carlos Jaime Pérez Índice 291 Colaboradores Dr. Carlos Almaguer Gaona Investigador Nacional, Sistema Nacional de Investigadores, Patólogo Clínico, Profesor de Hematología. Miembro de la Academia Nacional de Medicina y de la Academia Servicio de Hematología, Departamento de Medicina Interna, Mexicana de Ciencias. Centro Universitario contra el Cáncer, Facultad de Medicina y Hospital Universitario “Dr. José E. González” de la Universidad Dr. Miguel A. Gómez Guijosa Autónoma de Nuevo León, Monterrey, México Hematólogo. Servicio de Hematología, Departamento de Medici- na Interna, Centro Universitario contra el Cáncer, Facultad de Dra. Olga G. Cantú Rodríguez Medicina y Hospital Universitario “Dr. José E. González” de la Hematóloga, Profesora de Hematología y Medicina Interna. Universidad Autónoma de Nuevo León, Monterrey, México. Coordinadora del Programa de Trasplante de Células Hematopo- yéticas. Dr. Óscar González Llano Servicio de Hematología, Departamento de Medicina Interna, Hematólogo Pediatra, Profesor de Hematología. Centro Universitario contra el Cáncer, Facultad de Medicina y Servicio de Hematología, Departamento de Medicina Interna, Hospital Universitario “Dr. José E. González” de la Universidad Centro Universitario contra el Cáncer, Facultad de Medicina y Autónoma de Nuevo León, Monterrey, México. Hospital Universitario
Recommended publications
  • Correlation of Red Blood Cell Distribution Width (RDW) and Haemoglobin A1C (Hba1c) Levels in Diabetic Individuals
    ISSN(Online) : 2319-8753 ISSN (Print) : 2347-6710 International Journal of Innovative Research in Science, Engineering and Technology (An ISO 3297: 2007 Certified Organization) Website: www.ijirset.com Vol. 6, Issue 5, May 2017 Correlation of Red Blood Cell Distribution Width (RDW) and Haemoglobin A1C (HbA1C) Levels in Diabetic Individuals Ahmed Hasan Salimon, Dr.Harshal Anil Patil M. Sc Students, Department of Chemistry (Bio-Chemistry), Fergusson College Pune, Savitribai Phule Pune University, Pune, India Associate Consultant, Laboratory Ruby Hall Clinic, Pune, India ABSTRACT: Diabetes Mellitus (DM) is a metabolic disease characterized with persistent hyperglycemia due to , inappropriate glucose use or insufficient insulin production of pancreas. There is a defect in insulin effect, secretion or both. Due to sedentary life style and obesity, incidence of type 2 diabetes mellitus is increasing. Oral hypoglycaemic drugs or insulin therapy along with diet control and exercise helps the diabetic individual to keep proper glycemic control. Glycemic control is must in DM. Glycemic control is the main target of treatment in protection against organ damage and other complications of DM. Glycatedhemoglobin (HbA1C) follow-up is made in order to measure the efficiency of the treatment in DM and observe the glycemic control. HbA1C is formed as the result of non-enzymatic reaction of glucose to hemoglobin. It provides information on the average blood glucose levels of past 8-12 weeks in DM treatment. HbA1C is the golden standard in glycemic control of patients. Hyperglycemia tend to have effect on RBC survival and glycation of haemoglobin Red blood cell distribution width (RDW) is the symbol of red blood cell volume distribution width coefficient of variation.
    [Show full text]
  • A Study of the Neonatal Haematology of Children with Down Syndrome
    A study of the neonatal haematology of children with Down syndrome Rebecca James submitted in accordance with the requirements for the degree of Doctor of Philosophy Department of Health Sciences University of York, March 2011 Abstract This thesis describes the establishment and initial findings of the Children with Down Syndrome Study, a birth cohort of children with DS. The Children with Down Syndrome Study was set up in order to characterise the haematology of neonates with Down syndrome and specifically to test the hypothesis that that this differed in this population. The study was carried out with the support of the Down Syndrome Association and the Down Syndrome Medical Interest Group, and through consultation with clinicians and families. Following a pilot study in the Yorkshire region it was established in over 60 hospitals across the north of England. The Children with Down Syndrome Study is the largest birth cohort of children with Down syndrome established to date, and this is the largest reported analysis of the haematology of neonates with Down syndrome. The results confirm that neonates with Down syndrome have a distinct haematological profile. Means and ranges for haematological parameters throughout the neonatal period are provided. The effects of gestational age, birth weight, postnatal age and the venepuncture to processing interval on the neonatal full blood count were examined, and this is the first report of factors that influence the haematological parameters in neonates with Down syndrome. In order to analyse the blood cell morphology a new approach to morphology was developed and validated. Morphological review of samples from neonates with Down syndrome demonstrated that blasts were common.
    [Show full text]
  • Blood Count Free Download
    BLOOD COUNT FREE DOWNLOAD Robert Goddard | 464 pages | 16 Apr 2012 | Transworld Publishers Ltd | 9780552161305 | English | London, United Kingdom Understanding Blood Counts Red cell distribution width RDW is a measurement of the variation in the size of your red blood cells. White Blood Cells White blood cells, also called leukocytes, are cells that exist in the blood, the lymphatic systemand tissues and are an important part of the body's natural defense immune system. Manual platelet counts are performed in a similar manner, although some methods leave the red blood cells intact. The device was Blood Count designed for counting red blood cells, but with later modifications it proved effective for counting white blood cells. See the child's lab report for reference ranges. Accordion Title. Infection Inflammation Severe physical or emotional stress such as fever, injury or surgery Blood Count Kidney failure Lupus Rheumatoid arthritis Malnutrition, thyroid problems Certain medicines. Automated methods for measuring hemoglobin were developed in the s, and Maxwell Wintrobe introduced the Wintrobe hematocrit method inwhich in turn allowed him to define the red blood cell indices. Some therapies, such as chemotherapycan affect bone marrow production of cells. Louis: Mosby Elsevier;Pp Bleeding Blood Count. Assuming that the characteristics of the patient population remain roughly the same over time, the average should remain constant; large shifts in the average value can indicate instrument problems. What are thrombocythemia and thrombocytosis? The cell images are displayed to a human operator, who can Blood Count re-classify the cells if necessary. An abnormally low hemoglobin, hematocrit, or red blood cell count indicates anemia.
    [Show full text]
  • Chapter Preview
    A TEXT BOOK OF PHYSIOLOGY Dr. Pratiti Ghosh, FABMS Ex-Visiting Fellow, National Institutes of Health, USA. Associate Professor & Head Department of Physiology West Bengal State University Kolkata. MUMBAI NEW DELHI NAGPUR BENGALURU HYDERABAD CHENNAI PUNE LUCKNOW AHMEDABAD ERNAKULAM BHUBANESWAR INDORE KOLKATA GUWAHATI © Author No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording and/or otherwise without the prior written permission of the publisher. First Edition : 2015 Published by : Mrs. Meena Pandey for Himalaya Publishing House Pvt. Ltd., “Ramdoot”, Dr. Bhalerao Marg, Girgaon, Mumbai - 400 004. Phone: 022-23860170/23863863, Fax: 022-23877178 E-mail: [email protected]; Website: www.himpub.com Branch Offices : New Delhi : “Pooja Apartments”, 4-B, Murari Lal Street, Ansari Road, Darya Ganj, New Delhi - 110 002. Phone: 011-23270392, 23278631; Fax: 011-23256286 Nagpur : Kundanlal Chandak Industrial Estate, Ghat Road, Nagpur - 440 018. Phone: 0712-2738731, 3296733; Telefax: 0712-2721216 Bengaluru : No. 16/1 (Old 12/1), 1st Floor, Next to Hotel Highlands, Madhava Nagar, Race Course Road, Bengaluru - 560 001. Phone: 080-22286611, 22385461, 4113 8821, 22281541 Hyderabad : No. 3-4-184, Lingampally, Besides Raghavendra Swamy Matham, Kachiguda, Hyderabad - 500 027. Phone: 040-27560041, 27550139 Chennai : New-20, Old-59, Thirumalai Pillai Road, T. Nagar, Chennai - 600 017. Mobile: 9380460419 Pune : First Floor, "Laksha" Apartment, No. 527, Mehunpura, Shaniwarpeth (Near Prabhat Theatre), Pune - 411 030. Phone: 020-24496323/24496333; Mobile: 09370579333 Lucknow : House No 731, Shekhupura Colony, Near B.D. Convent School, Aliganj, Lucknow - 226 022. Phone: 0522-4012353; Mobile: 09307501549 Ahmedabad : 114, “SHAIL”, 1st Floor, Opp.
    [Show full text]
  • International Journal of Medical, Dental, and Allied Health Sciences
    International Journal of Medical, Dental, and Allied Health Sciences Original Article ACUTE TONSILLITIS AND ITS RELATIONSHIP WITH COMPLETE Publication History: BLOOD COUNT Published 1/1/2021 AUTHORS: DOI: 10.5281/zenodo.4430243 1. DR. WASEEM AHMAD, THQ HOSPITAL GOJRA 2. DR. SARTAJ ABBAS, DHQ HOSPITAL VEHARI 3. DR. HIRA AHSAN, FATIMA JINNAH MEDICAL UNIVERSITY LAHORE ABSTRACT: A complete blood count (CBC), also known as a full blood count (FBC), is a set of medical laboratory tests that provide information about the cells in a Corresponding Author: person's blood. The CBC indicates the counts of Dr. Hira Ahsan white blood cells, red blood cells and platelets, the Fatima Jinnah Medical concentration of hemoglobin, and the hematocrit University Lahore (the volume percentage of red blood cells). This [email protected] cross-sectional study was conducted among the patients presenting in the medical outdoor Cite this article as: department of different hospitals. Name, age, Ahmad W, Abbas S, gender and history and duration of acute tonsillitis Ahsan H. Acute tonsillitis were noted on a predefined proforma. Complete and its relationship with blood count reports of all the patients were taken complete blood count. Int. from the lab. All the data was entered and analyzed J. Med. Dent. Allied Health with SPSS Ver. 23.0. A total of 50 patients with Sci. 2020;3(1). 742-46 history of acute tonsillitis were included in this study i.e., 25 males (50%) and 25 females (50%). © Copyright 2020 The mean age of the patients was 31.34±5.21 This is an open access article years.
    [Show full text]
  • Blood Counts Free
    FREE BLOOD COUNTS PDF Martin O'Brien | 368 pages | 01 May 2014 | Cornerstone | 9781848090590 | English | London, United Kingdom What are low blood counts? | Aplastic Anemia & MDS International Foundation A complete blood count CBCalso known as a full blood count FBCis a set of medical laboratory tests that provide information about the cells in a person's blood. The CBC indicates the amounts of white blood cellsred blood cells and plateletsthe concentration of hemoglobinand the hematocrit the volume percentage of red blood cells. The red Blood Counts cell indiceswhich indicate the average size and hemoglobin content of red blood cells, are also reported, and a white blood cell differentialwhich counts the different types of Blood Counts blood cells, may be included. The CBC is often carried out as part of a medical assessment, and can be used to monitor health or diagnose diseases. The results are interpreted by comparing them to reference rangeswhich vary with gender and age. Conditions like anemia and thrombocytopenia are defined by abnormal complete blood count results. The red blood cell indices can provide information about the cause of a person's anemia such as iron deficiency and vitamin B12 deficiencyand the results of the white blood cell differential can help to diagnose viralbacterial and parasitic infections and blood disorders like leukemia. Not all results falling outside of the reference range require medical intervention. The CBC is performed using basic laboratory equipment or an automated hematology analyzerwhich counts red and white Blood Counts cells and platelets and collects information on their size Blood Counts structure. The concentration of hemoglobin is measured, and the red blood cell indices are calculated from measurements of red Blood Counts cells and hemoglobin.
    [Show full text]
  • Erythroblastosis Fetalis
    Cambridge University Press 978-1-108-48898-3 — Neonatal Hematology 3rd Edition Excerpt More Information Section I Developmental Hematology Chapter A Historical Review 1 Howard A. Pearson Ancient concepts of the blood were described by red in color ...These particles are so minute that Hippocrates and Galen 2000 years ago in their 100 of them placed side by side would not equal doctrine of “humors.” It was believed that the the diameter of a common grain of sand. body was made up of four humors – blood, In the centuries following, the development of phlegm, black bile, and yellow bile – and that compound microscopes with two lenses greatly these four components had the qualities of heat increased magnification and minimized spherical (hot-blooded!), cold, moist, and dry. The Galenic aberration, permitting more accurate descriptions concept of the blood prevailed through the Middle of the blood cells. Dr. William Hewson, who has Ages. Health or disease were a result of an imbal- been designated as one of the “fathers of hematol- ance, between these humors. This was the basis of ogy,” noted that the red cells were flat rather than the practice of therapeutic bloodletting (which, globular and also described the leukocytes for the fortunately, was performed infrequently on chil- first time [3]. The last of the formed elements of dren) through the mid nineteenth century as the blood, the platelet, was recognized indepen- a way to rid the body of the imbalance of humors dently by several investigators. The most defini- believed to cause a wide variety of diseases. tive early work on the platelet was done by Giulio The hematology of the fetus and newborn is Bizzozero.
    [Show full text]
  • Laboratory Diagnosis of Anemia: Are the Old and New Red Cell Parameters Useful in Classification and Treatment, How?
    International Journal of Laboratory Hematology The Official journal of the International Society for Laboratory Hematology REVIEW ARTICLE INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how? M. BUTTARELLO Clinical Pathology Laboratory, SUMMARY Hospital of Adria, Adria (RO), Italy Introduction: Anemia is a global problem affecting the population in both developing and developed countries, and there is a debate on correspondence: Mauro Buttarello, Clinical which hemoglobin level limit should be used to define anemia in Pathology Laboratory, Hospital general population and particularly in the elderly. We present of Adria, ULSS 19 Piazza degli herein a laboratory approach to diagnosing the possible causes of Etruschi, 45011 Adria (RO), anemia based on traditional and new erythroid parameters. In this Italy. Tel.: 00393407719537; E-mail: [email protected] article, we provide practical diagnostic algorithms that address to differential diagnosis of anemia. Based on both morphological and kinetic classifications, three patterns were considered: microcytic, doi:10.1111/ijlh.12500 normocytic, and macrocytic. Methods: Main interest is on the clinical usefulness of old and new accepted for publication 4 April parameters such as mean cell volume (MCV), red blood cell distri- 2016 bution width (RDW), hypochromic and microcytic erythrocytes, Keywords immature reticulocyte fraction (IRF), and some reticulocyte indices Anemia, red cell indices, reticu- such as reticulocyte hemoglobin content and mean reticulocyte locytes, immature reticulocyte volume. The pathophysiologic basis is reviewed in terms of bone fraction, reticulocyte hemoglo- marrow erythropoiesis, evaluated by reticulocyte count (increased bin content, mean reticulocyte volume or normal/decreased) and IRF.
    [Show full text]
  • The Correlation Between the Levels of Education of Clinical Laboratory Personnel and the Accuracy of Peripheral Blood Smear Results
    Walden University ScholarWorks Walden Dissertations and Doctoral Studies Walden Dissertations and Doctoral Studies Collection 2001 The orC relation Between the Levels of Education of Clinical Laboratory Personnel and the Accuracy of Peripheral Blood Smear Results Susan J. Leclair Walden University Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations Part of the Equipment and Supplies Commons, Health and Medical Administration Commons, and the Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion. Oversize materials (e.g., maps, drawings, charts) are reproduced by sectioning the original, beginning at the upper left-hand comer and continuing from left to right in equal sections with small overlaps.
    [Show full text]
  • Clinicalcancerprogram
    The Clinical CancerProgram at YALE by david s. fischer, md THE SMILOW CANCER HOSPITAL AT YALE-NEW HAVEN sterling hall of medicine on 200th anniversary of yale school of medicine david s. fischer, md david the smilow cancer hospital at yale-new haven 2009 Notice: Every effort has been made to ensure that the facts in this publication are correct, but since some of this is oral history, errors will occur in spite of attempts to verify the facts in published accounts. In a few instances, published accounts were apparently in error according to reports of multiple individuals who had contemporary personal knowledge of the events. The interpretation of events is subjective and individuals may view them differently. The opinions and interpretations herein are the responsibility of the author and not of the individuals consulted or those who reviewed all or portions of the manuscript. Y printing and publishing services Frank Savino, Publication Operations Andrea Porto, Graphic Designer, Prepress Operator John Heine, Design and Prepress Copyright 2012 by David S. Fischer, MD ISBN 978-0-9797398-6-6 The Clinical Cancer Program at Yale Table of Contents Introduction 1 Founding of Yale College 2 The Medical Community in Colonial Times 5 Yale School of Medicine (YSM) 6 Abraham Flexner 9 Dean Milton C. Winternitz, MD 11 Deans of the Yale School of Medicine 13 Rectors of the Collegiate School 13 Presidents of Yale College (after 1887, University) 14 World War II and Nitrogen Mustard 14 Yale’s Contributions to the War Effort 16 Financial Problems at the Medical School 17 Yale New-Haven Hospital (YNHH) 19 Other Hospitals 21 Beginning Interest in Cancer 23 The Cancer Committee 24 Members of the Cancer Committee in 2008 26 Department of Pharmacology 27 Chairs of the Department of Pharmacology 28 Arnold D.
    [Show full text]
  • It's in the Blood: the Varieties of Linus Pauling's Work on Hemoglobin and Sickle Cell Anemia
    AN ABSTRACT OF THE THESIS OF Melinda Gormley for the degree of Master of Science in History of Science presented on October 22. 2003. Title: It's in the Blood: The Varieties of Linus Pauling's Work on Hemoglobin and Sickle Cell Anemia approved: Mary Jo Nye Linus Pauling incorporated hemoglobin and a disease of the blood, sickle cell anemia, into many of his researches between the mid-1930s and mid-1970s. In the early 1 930s Pauling became interested in organic chemistry and named hemoglobin as one of the first biochemical substances that he planned to analyze. In 1935 he published his first paper on hemoglobin, which determined the structure of the four hemes in hemoglobin. Pauling continued to study the structure of hemoglobin until the early 1950s when he proposed that it was an alpha-helix. In 1945 Pauling learned about sickle cell anemia and published an important paper in 1949 with Harvey A. Itano, S. J. Singer, and Ibert C. Wells titled "Sickle Cell Anemia, a Molecular Disease." Pauling investigated hemoglobin into the mid-1970s when he tried to find an orthomolecular therapy for sickle cell anemia. From the mid-1950s to early 1970s, Pauling also used sickle cell anemia to promote negative eugenics, point out the possible mutagenic effects caused by nuclear weapons testing, and propose an evolutionary theory. Additionally, in the final year of his life, Pauling wrote two forewords for books on sickle cell anemia, which were published in 1994, theyear he died. Hemoglobin and sickle cell anemia can be considered a theme within Pauling's work.
    [Show full text]